Functional imaging of the cerebral olfactory system in patients with Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 1, 2008, Pages 19-24

  Westermann, B ^a,b   Wattendorf, E ^b,c   Schwerdtfeger, U ^b   Husner, A ^b   Fuhr, P ^a   Gratzl, O ^a   Hummel, T ^d   Bilecen, D ^b   Welge Lussen A ^b  

^a Neurologische Universitatsklinik Basel   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF DRESDEN MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMYGDALOID NUCLEUS; ANALYTIC METHOD; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MALE; NERVE CELL; OLFACTORY SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; SMELLING DISORDER;

ADULT; AGED; AMYGDALA; BRAIN; CORPUS STRIATUM; FEMALE; FUNCTIONAL LATERALITY; GYRUS CINGULI; HUMANS; LEWY BODIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OLFACTION DISORDERS; PARKINSON DISEASE; PREFRONTAL CORTEX;

EID: 37749020081     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.113860     Document Type: Article

References (40)

1. Braak H, Rub U, Gai WP, et al. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003;110:517-36.
2. Pensen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-81.
3. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004;19:1196-202.
4. Doty RL Shaman P, Dann M. Development of the University of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984;32:489-502.
5. Hummel T, Sekinger B, Wolf SR, et al. 'Sniffin' Sticks': Olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997;22:39-52.
6. Daum RF, Sekinger B, Kobal G, et al. Olfactory testing with "sniffin' sticks" in idiopathic Parkinsonism. Nervenarzt 2000;71:643-50.
7. Doty RL, Riklan M, Deems DA, et al. The olfactory and cognitive deficits of Parkinsons disease - evidence for independence. Ann Neurol 1989;25:166-71.
8. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism - a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-44.
9. Tissingh G, Berendse HW, Bergmans P, et al. Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord 2001;16:41-6.
10. Hummel T. Olfactory evoked potentials as a tool to measure progression of Parkinson's Disease. In: Chase T, Bedrad P, eds. Focus on Medicine Vol. 14 - New developments in the drug therapy of Parkinson's disease. Oxford: Blackwell Science, 1999:47-53.
11. Siderowf A, Newberg A, Chou KL, et al. [Tc-99m] TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 2005;64:1716-20.
12. Huisman E, Uylings HBM, Hoogland PV. A 100% increase of 687 dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 2004;19:687-92.
13. Harding AJ, Stimson E, Henderson JM, et al. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain 2002;125:2431-45.
14. Pearce RKB, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson's disease. Mov Disord 1995;10:283-7.
15. Royet JP, Plailly J, Delon-Martin C, et al. fMRI of emotional responses to odors: influence of hedonic valence and judgment, handedness, and gender. Neuroimage 2003;20:713-28.
16. Poellinger A, Thomas R, Lio P, et al. Activation and habituation in olfaction - an fMRI study. Neuroimage 2001;13:547- 60.
17. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.
18. Hoehn MM, Yahr MD. Parkinsonism - onset progression and mortality. Neurology 1967;17:427-42.
19. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Health Care Information, 1987:153-64.
20. Folstein MF, Folstein SE, Mchugh PR. Mini-mental state - practical method for grading cognitive state of patients for clinician. J Psychiatr Res 1975;12:189-98.
21. Beck AT, Erbaugh J, Ward CH, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
22. Kobal G, Klimek L, Wolfensberger M, et al. Multicenter investigation of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 2000;257:205-11.
23. Doty RL, Stern MB, Pfeiffer C, et al. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:138-42.
24. Radil T, Roth J, Ruzicka E, et al. Olfactory dysfunction: A symptom of Parkinson's disease? Ceska A Slovenska Neurologie A Neurochirurgie 1995;58:286-9.
25. Levy LM, Henkin RI, Lin CS, et al. Odor memory induces brain activation as measured by functional MRI. J Comput Assist Tomogr 1999;23:487-98.
26. Friston KJ, Holmes AP, Worsley KJ, et al. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210.
27. Sobel N, Prabhakaran V, Zhao Z, et al. Time course of odorant-induced activation in the human primary olfactory cortex. J Neurophysiol 2000;83:537-51.
28. Worsley KJ, Marrett S, Neelin P, et al. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996;4:58-73.
29. Winston JS, Gottfried JA, Kilner JM, et al. Integrated neural representations of odor intensity and affective valence in human amygdala. J Neurosci 2005;25:8903-7.
30. Calvert GA, Hansen PC, Iversen SD, et al. Detection of audio-visual integration sites in humans by application of electrophysiological criteria to the BOLD effect. Neuroimage 2001;14:427-38.
31. Elliott R, Frith CD, Dolan RJ. Differential neural response to positive and negative feedback in planning and guessing tasks. Neuropsychologia 1997;35:1395-404.
32. Rolls ET. Precis of the brain and emotion. Behav Brain Sci 2000;23:177-91.
33. Cools R, Barker RA, Sahakian BJ, et al. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001;11:1136-43.
34. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease - pathophysiologic and clinical implications. N Engl J Med 1988;318:876-80.
35. Ferdon S, Murphy C. The cerebellum and olfaction in the aging brain: a functional magnetic resonance imaging study. Neuroimage 2003;20:12-21.
36. Kobal G, Hummel T, Vantoller S. Differences in human chemosensory evoked-potentials to olfactory and somatosensory chemical stimuli presented to left and right nostrils. Chem Senses 1992;17:233-44.
37. Samuel M, Ceballos-Baumann AO, Blin J, et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements - A PET study. Brain 1997;120:963-76.
38. Monchi O, Petrides M, Doyon J, et al. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 2004;24:702-10.
39. Grossman M, Cooke A, DeVita C, et al. Grammatical and resource components of sentence processing in Parkinson's disease - An fMRI study. Neurology 2003;60:775-81.
40. Bruck A, Aalto S, Nurmi E, et al. Striatal subregional 6-[F-18]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study. Mov Disord 2006;21:958-6.